PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
15-Jul-2022 Gene Editing Tools Market is likely to grow at a CAGR of over 18.8% during the period 2022-2029 MARKITWIRED
15-Jul-2022 Multi-Parameter Patient Monitoring Market is anticipated to increase at a CAGR of 4.6% 2022-2028 MARKITWIRED
15-Jul-2022 Global Injectable Drug Delivery Market Report 2022-2028 with Key Company Analysis of Pfizer, GSK, Eli Lilly, Baxter and BD and Co - ResearchAndMarkets.com Businesswire
15-Jul-2022 Aemia Treatment Market size is projected to total US$ 14.9 Billion by 2028 MARKITWIRED
15-Jul-2022 Cytomegalovirus Treatment Market currently stands at US$ 228.8 Million in 2022 MARKITWIRED
15-Jul-2022 Cardiac Rhythm Management Devices Market Size, Status and Business Growth 2022 to 2030 We Market Research
15-Jul-2022 Bronchoscopes Market is projected to reach a valuation of U.S. $ 480.3 Million over the forecast period of 2022-2028 MARKITWIRED
15-Jul-2022 OMass Therapeutics Appoints Dr Jon Roffey as Vice President, Head of Medicinal Chemistry OMass Therapeutics
15-Jul-2022 15th Edition Portfolio Management And Pipeline Optimization For Generics marcus evans
15-Jul-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
15-Jul-2022 NOXXON Pharma Announces Name Change to “TME Pharma” and New Trading Symbol Businesswire
15-Jul-2022 Endostart Appoints Christopher Rowland Chairman of the Company’s Board of Directors. Businesswire
15-Jul-2022 Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Approval of exsig™ COVID-19 Direct Test in the UK Under CTDA Legislation Businesswire
15-Jul-2022 How is Prevalence of Genetic Diseases Driving Carrier Screening Market? P&S Intelligence
15-Jul-2022 Growing Elderly Population Leads to Benign Prostatic Hyperplasia Treatment Market Expansion P&S Intelligence
15-Jul-2022 Polpharma Biologics Announces EMA Acceptance of Marketing Authorization Application for Proposed Biosimilar Natalizumab B3C newswire
15-Jul-2022 Dermaliq nomme Gordon Dow, PharmD, Michael Kuligowski, MD, PhD, R. Todd Plott, MD et Xavier Yon à son comité consultatif scientifique et médical en dermatologie Businesswire
15-Jul-2022 Labcorp to Announce Second Quarter Financial Results on July 28, 2022 Businesswire
15-Jul-2022 Dermaliq benoemt Gordon Dow, PharmD, Michael Kuligowski, MD, PhD, R. Todd Plott, MD en Xavier Yon tot zijn wetenschappelijke en medische adviesraad voor dermatologie Businesswire
15-Jul-2022 Dermaliq nomina Gordon Dow, PharmD, Michael Kuligowski, MD, PhD, R. Todd Plott, MD e Xavier Yon nel suo comitato consultivo medico-scientifico per la dermatologia. Businesswire